Chemical Research in Chinese Universities ›› 2018, Vol. 34 ›› Issue (1): 24-27.doi: 10.1007/s40242-018-7295-y

• Articles • Previous Articles     Next Articles

Development of BCPDA-Eu3+-BAS Labeled Hepatitis B Surface Antibodies

TAN Wenjia1, SUN Zhixia1, XUAN Lili1, LI Junling2, XIE Wenbing2, HE Chengyan1, PAN Lihua2   

  1. 1. China-Japan Union Hospital of Jilin University, Changchun 130033, P. R. China;
    2. Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, P. R. China
  • Received:2017-09-06 Online:2018-02-01 Published:2018-01-20
  • Contact: HE Chengyan,E-mail:chengyanhe469@vip.sina.com;PAN Lihua,E-mail:lihuap@ciac.ac.cn E-mail:chengyanhe469@vip.sina.com;lihuap@ciac.ac.cn
  • Supported by:
    Supported by the National Natural Science Foundation of China(No.81572082) and the Natural Science Foundation of Jilin Province, China(Nos.2011713, 20150414015GH, 20150204010YY).

Abstract: The effect of the chelating agent 4,7-bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid (BCPDA) labeled hepatitis B surface antibodies(HBsAb) on time-resolved fluoroimmunoassays(TRFIA) was investigated. The labeling detection method was established. The biotin-streptavidin(BAS) system was introduced, and the multi-stage amplification effect of the BAS system was analyzed. It is found that the BCPDA-Eu3+-HBsAb-BAS fluorescent marker can emit strong fluorescence. Compared to BCPDA-Eu3+-HBsAb, BCPDA-Eu3+-HBsAb-BAS demonstrates an enhanced fluorescence intensity by over 10 times. This study provides a guidance for the next gene- ration non-radio immunoassays in clinical diagnosis.

Key words: Time-resolved fluorescence immunoassay, Biotin, Streptavidin